Cytek Biosciences, Inc. (CTKB)
Builds machines that analyze and sort cells for drug development and medical research.
$4.46+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+22.5%
The outlook
CTKB trades near the lower end of its 52-week range at $4.46, with a mixed technical picture against moving averages. Analyst coverage leans constructive, with the average price target sitting about 28% above the current level. Overall sentiment is neutral, reflecting modest optimism tempered by the stock's recent positioning.
What’s behind the score
Price trendMixed vs its moving averages
52-week range41% of the way from its 52-week low to high
Price targetAvg target +28% vs current price
Analyst price target
~12-month · 4 analysts$5.69average target+27.5% vs now
Now $4.46
Low $4.75High $7.50
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$576.0M
52-wk high
$6.18
52-wk low
$3.28
50-day avg
$4.22
200-day avg
$4.56
Trailing P/E
—